| P50 | author | Matthew Greer | Q57576966 |
| | Baris Turkbey | Q88769455 |
| | Peter L Choyke | Q90059714 |
| P2860 | cites work | Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging | Q22065375 |
| | ESUR prostate MR guidelines 2012 | Q24620926 |
| | Prostate MRI based on PI-RADS version 2: how we review and report | Q26749289 |
| | PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 |
| | Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. | Q30664726 |
| | Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis | Q30873946 |
| | Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference | Q30995961 |
| | Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology | Q33590993 |
| | A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial | Q33745912 |
| | Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. | Q33773593 |
| | Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? | Q34534796 |
| | Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer. | Q35163748 |
| | Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate. | Q35197378 |
| | Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer | Q35932176 |
| | Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer | Q35985579 |
| | Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection | Q35996363 |
| | PIRADS 2.0: what is new? | Q36018710 |
| | Prostate MR imaging at high-field strength: evolution or revolution? | Q36254924 |
| | Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. | Q36386904 |
| | Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging | Q36434291 |
| | Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. | Q36818183 |
| | Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 |
| | Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance | Q37424778 |
| | Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting | Q37825030 |
| | Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer | Q37866554 |
| | Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). | Q37873396 |
| | Prostate imaging: evaluation of a reusable two-channel endorectal receiver coil for MR imaging at 1.5 T. | Q38182636 |
| | MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation | Q38185148 |
| | Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. | Q38220925 |
| | Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis | Q38555364 |
| | The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer | Q38577959 |
| | Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy | Q38734921 |
| | A practical primer on PI-RADS version 2: a pictorial essay. | Q38777739 |
| | Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go? | Q38780669 |
| | Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems. | Q38786175 |
| | The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer | Q39765676 |
| | Validation of PI-RADS v.2 for prostate cancer diagnosis with MRI at 3T using an external phased-array coil | Q39821295 |
| | Assessment of PI-RADS v2 for the Detection of Prostate Cancer | Q39925072 |
| | Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy | Q39947142 |
| | Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen | Q40062114 |
| | PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer. | Q40928990 |
| | Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer | Q41217678 |
| | Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes | Q42007796 |
| | 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy | Q44477215 |
| | Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection. | Q44557996 |
| | Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. | Q46172434 |
| | Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis. | Q46855005 |
| | MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy | Q46903275 |
| | T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance. | Q52852580 |
| | MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. | Q52936107 |
| | MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. | Q52967028 |
| | Head-to-head comparison of PI-RADS v2 and PI-RADS v1. | Q53105059 |
| | Does Abstinence From Ejaculation Before Prostate MRI Improve Evaluation of the Seminal Vesicles? | Q57317458 |
| | Prostate Cancer: Comparison of Tumor Visibility on Trace Diffusion-Weighted Images and the Apparent Diffusion Coefficient Map | Q57385827 |
| | Prostate cancer vs. post-biopsy hemorrhage: Diagnosis with T2- and diffusion-weighted imaging | Q57385830 |
| P433 | issue | 1 | |
| P304 | page(s) | 11-23 | |
| P577 | publication date | 2017-02-25 | |
| P1433 | published in | Journal of Magnetic Resonance Imaging | Q15761156 |
| P1476 | title | PI-RADSv2: How we do it. | |
| P478 | volume | 46 | |